Cancer risk and key components of metabolic syndrome: A population-based prospective cohort study in Chinese

Chinese Medical Journal

Volumn 125, Issue 3, 2012, Pages 481-485

  Chen, Wei ^a   Lu, Feng ^a   Liu, Si Jun ^a   Du, Jiang Bo ^a   Wang, Jian Ming ^a   Qian, Yun ^a   Shen, Chong ^a   Jin, Guang Fu ^a   Hu, Zhi Bin ^a   Shen, Hong Bing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; Cohort study; Metabolic components; Metabolic syndrome; Risk factors

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CANCER INCIDENCE; CANCER RISK; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTERVIEW; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PROSPECTIVE STUDY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROSPECTIVE STUDIES; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84863063115     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.03.015     Document Type: Article

References (27)

1. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, et al. Emergence of chronic non-communicable diseases in China. Lancet 2008; 372: 1697-1705.
2. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet 2005; 366: 1821-1824.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
5. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
6. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The national cholesterol education program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30: 8-13.
7. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007; 30: 561-567.
8. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
9. Martin RM, Vatten L, Gunnell D, Romundstad P. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer Causes Control 2010; 21: 463-472.
10. Johansen D, Stocks T, Jonsson H, Lindkvist B. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580 000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev 2010; 19: 2307-2317.
11. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
12. Lee JS, Cho SI, Park HS. Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 2009; 21: 640-645.
13. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
14. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 2007; 120: 140-146.
15. Sjodahl K, Lu Y, Nilsen TI, Ye W. Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 2007; 120: 128-132.
16. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008; 44: 293-297.
17. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107: 28-36.
18. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006; 15: 2391-2397.
19. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A, Salonen JT, et al. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1646-1650.
20. Lund Haheim L, Wisloff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006; 164: 769-774.
21. Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 2006; 164: 1094-1102.
22. Brodsky SV, Morrishow AM, Dharia N, Gross SS, Goligorsky MS. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 2001; 280: F480-F486.
23. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56.
24. Zhang WL, Zhao YL, Liu XM, Chen J, Zhang D. Protective role of mitochondrial K-ATP channel and mitochondrial membrane transport pore in rat kidney ischemic postconditioning. Chin Med J 2011; 124: 2191-2195.
25. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
26. Hou WK, Xu YX, Yu T. Adipocytokines and breast cancer risk. Chin Med J 2007; 120: 1592-1596.
27. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006; 169: 1505-1522.